To the question of the main of acute urinary retention development during myocardial infarction in young and middle-aged men predictors

Abstract

BACKGROUND: Importance in assessing the course and prognosis of myocardial infarction is given to the study of a combination of two or more chronic diseases in one patient, interconnected by a single pathogenetic mechanism. Urological diseases are not among the most common in myocardial infarction, but during this period they significantly worsen the quality of life, increase the cost of treatment and are also associated with a worse prognosis.

AIM: To study the development of acute urinary retention during the acute and subacute periods of myocardial infarction risk factors in men under 60 years old to improve prevention and outcomes.

MATERIALS AND METHODS: The study included men aged 19–60 years with type I myocardial infarction. Patients were divided into two age-comparable groups: I — study group, with acute urinary retention — 22 patients; II — control, without urination disorders — 644 patients. A comparative analysis of the main and additional cardiovascular risk factors observation frequency, the features of the clinical course in the selected groups were performed. Pearson’s Chi-square method was used to analyze the risks of developing acute urinary retention.

RESULTS: The structure of cardiovascular risk factors in the study group differed from the control group in a higher frequency of coronary artery bypass surgery in the medical history (I: 31.8%; II: 8.4%; p = 0.0002) and pacing (9.1 and 0.5%; respectively; p < 0.0001), as well as fibrillation and/or atrial flutter in the medical history (27.3 and 9.2%; p = 0.005), chronic cerebrovascular insufficiency (77.3 and 51.3%; p = 0.02), alcohol abuse (63.6 and 25.2%; p < 0.0001), frequent (four and more per year) colds (27.3 and 12.6%; p = 0.04), cardiac arrhythmias and conduction disorders at the onset of coronary artery disease (61.9 and 24.9%; p = 0.0007), smoking for 20 years or more (36.4 and 16.8%; p = 0.003), chronic kidney disease (46.7 and 16.2%; p = 0.02), chronic infection foci of internal organs (77.3 and 39.4%; p = 0.002), urinary (27.3 and 8.6%; p = 0.006) and cholelithiasis (13.6 and 5.4%; p = 0.006). Among the features of the clinical course of the disease, the study group was distinguished by a higher incidence of multiple complications of myocardial infarction (100 and 44.0%; p < 0.0001), severe and extremely severe condition of patients (59.0 and 19.6%; p < 0.0001). Asystole (absolute risk: 42.1%; relative: 18.0; p < 0.0001), hydrothorax (absolute risk: 41.7%; relative: 15.9; p < 0.0001), the patient’s severe condition in the first hours of illness (absolute risk: 100%; relative: 36.5; p < 0.0001), alcohol abuse (8.0%; 4.9; p < 0.0001), smoking (absolute risk: 4.4%; relative: 8.0; p = 0.01) and onset of CHD with heart rhythm and conduction disturbances (7.7%; 4.6; p = 0.0001) were the most significant predictors of acute urinary retention.

CONCLUSIONS: Patients with acute urinary retention are characterized by a more severe course of myocardial infarction. Combinations of listed above factors indicate an increased risk of developing this complication. It is advisable to use them for predictive modeling and the formation of risk groups for early prevention.

Keywords

acute urinary retention / complications / course features / heart failure / lower urinary tract syndrome / myocardial infarction / prevention / risk factors / young and middle-aged men

References

[1] Zykov MV, Kashtalap VV, Poltaranina VA, et al. Predictive importance of comorbidity in patients with myocardial infarction and different strategy of treatment. Medical alphabet. 2019;2(30(405)): 33–36. (In Russ.) DOI: 10.33667/2078-5631-2019-2-30(405)-33-36

[2] Зыков М.В., Кашталап В.В., Полтаранина В.А., и др. Прогностическая значимость коморбидности у пациентов с инфарктом миокарда и разными стратегиями лечения // Медицинский алфавит. 2019. Т. 2, № 30(405). С. 33–36. DOI: 10.33667/2078-5631-2019-2-30(405)-33-36

[3] Johans CE, Bajic P, Kirshenbaum E, et al. Metabolic Syndrome Increases Risk of Postoperative Myocardial Infarction Following Percutaneous Nephrolithotomy. J Endourol. 2018;32(11):1039–1043. PMID: 30129773. DOI: 10.1089/end.2018.0519.

[4] Johans C.E., Bajic P., Kirshenbaum E., et al. Metabolic Syndrome Increases Risk of Postoperative Myocardial Infarction Following Percutaneous Nephrolithotomy // J. Endourol. 2018. Vol. 32, No. 11. P. 1039–1043. PMID: 30129773. DOI: 10.1089/end.2018.0519.

[5] Lai CH, Huang LC, Holby SN, et al. Kidney Stone History and Adverse Outcomes After Percutaneous Coronary Intervention. Urology. 2020;136:75–81. DOI: 10.1016/j.urology.2019.10.009

[6] Lai C.H., Huang L.C., Holby S.N., et al. Kidney Stone History and Adverse Outcomes After Percutaneous Coronary Intervention // Urology. 2020. Vol. 136. P. 75–81. DOI: 10.1016/j.urology.2019.10.009

[7] Lin SK, Liu JM, Chang YH, et al. Increased risk of endotracheal intubation and heart failure following acute myocardial infarction in patients with urolithiasis: a nationwide population-based study. Ther Clin Risk Manag. 2017;13:245–253. DOI: 10.2147/TCRM.S123702

[8] Lin S.K., Liu J.M., Chang Y.H., et al. Increased risk of endotracheal intubation and heart failure following acute myocardial infarction in patients with urolithiasis: a nationwide population-based study // Ther. Clin. Risk Manag. 2017. Vol. 13. P. 245–253. DOI: 10.2147/TCRM.S123702

[9] Sandoval Y, Smith SW, Sexter A, et al. Incidence and Prognostic Impact of Infection in Patients with Type 1 and 2 Myocardial Infarction. Clin Chem. 2020;66(9):1240–1241. DOI: 10.1093/clinchem/hvaa138

[10] Sandoval Y., Smith S.W., Sexter A., et al. Incidence and Prognostic Impact of Infection in Patients with Type 1 and 2 Myocardial Infarction // Clin. Chem. 2020. Vol. 66, No. 9. P. 1240–1241. DOI: 10.1093/clinchem/hvaa138

[11] Protoshchak VV, Paronnikov MV, Iglovikov NYu, et al. Prevalence of lower urinary tract symptoms, androgen deficiency and erectile dysfunction in young military personnel. Military-medical journal. 2019;340(11):42–47. (In Russ.)

[12] Протощак В.В., Паронников М.В., Игловиков Н.Ю., и др. Распространенность симптомов нижних мочевых путей андрогенного дефицита и эректильной дисфункции у военнослужащих молодого возраста // Военно-медицинский журнал. 2019. Т. 340, № 11. С. 42–47.

[13] Korneyev IA, Alekseyeva TA, Potapova MK, et al. Lower urinary tract symptoms in young adult men: analysis of prevalence, profile and relationship with metabolic syndrome’ risk factors. Urology. 2019;(1):47–51. (In Russ.) DOI: 10.18565/urology.2019.1.47-51

[14] Корнеев И.А., Алексеева Т.А., Потапова М.К., и др. Расстройства мочеиспускания у мужчин молодого возраста: анализ распространенности, структуры и связей с факторами риска развития метаболического синдрома // Урология. 2019. № 1. С. 47–51. DOI: 10.18565/urology.2019.1.47-51

[15] Kim SY, Bang W, Kim MS, et al. Nocturia is Associated with Slipping and Falling. PLoS One. 2017;12(1):е0169690. DOI: 10.1371/journal.pone.0169690

[16] Kim S.Y., Bang W., Kim M.S., et al. Nocturia is Associated with Slipping and Falling // PLoS One. 2017. Vol. 12, No. 1. P. е 0169690. DOI: 10.1371/journal.pone.0169690

[17] Srettabunjong S. Sudden Unexplained Nocturnal Death Syndrome: Epidemiological and Morphological Characteristics in Thai Autopsy Cases. J Forensic Sci. 2019;64(3):773–777. DOI: 10.1111/1556-4029.13924

[18] Srettabunjong S. Sudden Unexplained Nocturnal Death Syndrome: Epidemiological and Morphological Characteristics in Thai Autopsy Cases // J. Forensic. Sci. 2019. Vol. 64, No. 3. P. 773–777. DOI: 10.1111/1556-4029.13924

[19] Kloner RA, Carson C 3rd, Dobs A, et al. Testosterone and Cardiovascular Disease. J Am Coll Cardiol. 2016;67(5):545–557. DOI: 10.1016/j.jacc.2015.12.005

[20] Kloner R.A., Carson C. 3rd, Dobs A., et al. Testosterone and Cardiovascular Disease // J. Am. Coll. Cardiol. 2016. Vol. 67, No. 5. P. 545–557. DOI: 10.1016/j.jacc.2015.12.005

[21] Gagliano-Jucá T, Basaria S. Testosterone replacement therapy and cardiovascular risk. Nat Rev Cardiol. 2019;16(9):555–574. DOI: 10.1038/s41569-019-0211-4

[22] Gagliano-Jucá T., Basaria S. Testosterone replacement therapy and cardiovascular risk // Nat. Rev. Cardiol. 2019. Vol. 16, No. 9. P. 555–574. DOI: 10.1038/s41569-019-0211-4

[23] Jiang DD, Gillis KA, Chen Y, Hedges JC, Chakiryan NH. Perioperative stroke and myocardial infarction in urologic surgery. Can J Urol. 2021; 28(3): 10678–10684.

[24] -Jiang D.D., Gillis K.A., Chen Y., Hedges J.C., Chakiryan N.H. Perioperative stroke and myocardial infarction in urologic surgery // Can. J. Urol. 2021. Vol. 28, No. 3. P. 10678–10684.

[25] Kryukov EV, Shakhnovich PG, Tagirova GK, et al. The search for modern laboratory diagnostic predictors of the effectiveness of percutaneous coronary intervention in patients with coronary heart disease. Russian Cardiology Bulletin. 2020;(S):55–56. (In Russ.)

[26] Крюков Е.В., Шахнович П.Г., Тагирова Г.К., и др. Поиск современных лабораторно-диагностических предикторов эффективности чрескожного коронарного вмешательства у больных с ишемической болезнью сердца // Кардиологический вестник. 2020. № S. С. 55–56.

[27] Novikov VA, Gulyaev NI, Grechanik PM, Sotnikov AV. Dynamics of clinical manifestation of signs of heart failure in patient in young and middle age during a long period of myocardial infarction. Military-Medical Journal. 2009;330(5):68–69. (In Russ.)

[28] Новиков В.А., Гуляев Н.И., Гречаник П.М., Сотников А.В. Динамика клинических проявлений признаков сердечной недостаточности у больных молодого и среднего возраста в отдаленный период инфаркта миокарда // Военно-медицинский журнал. 2009. T. 330, № 5. С. 68–69.

[29] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237–269. DOI: 10.1093/eurheartj/ehy462

[30] Thygesen K., Alpert J.S., Jaffe A.S., et al. Fourth universal definition of myocardial infarction (2018) // Eur. Heart J. 2019. Vol. 40, No. 3. P. 237–269. DOI: 10.1093/eurheartj/ehy462

[31] Moiseyev VS, Mukhin NA, Smirnov AV, et al. Cardiovascular risk and chronic kidney disease: cardio-nephroprotection strategies. Terapiya. 2015;1(1):63–96. (In Russ.)

[32] Моисеев В.С., Мухин Н.А., Смирнов А.В., и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардионефропротекции. Национальные рекомендации // Терапия. 2015. T. 1, № 1. С. 63–96.

[33] Gordienko AV, Sotnikov AV, Nosovich DV, et al. Interrelation of risk factors of cardiovascular diseases and professional activity in men under 60 years old with myocardial infarction. Medicine: theory and practice. 2017;2(4):19–26. (In Russ.)

[34] Гордиенко А.В., Сотников А.В., Носович Д.В., и др. Взаимосвязь факторов риска кардиоваскулярных заболеваний и профессиональной активности у мужчин моложе 60 лет с инфарктом миокарда // Медицина: теория и практика. 2017. Т. 2, № 4. С. 19–26.

[35] Gordienko AV, Lukichev BG, Sotnikov AV, et al. Cardiovascular risk factors in men under 60 years old with myocardial infarction and renal dysfunction in different seasons of a year. Nefrologiya. 2018;22(6):64–69. (In Russ.) DOI: 10.24884/1561-6274-2018-22-6-64-69

[36] Гордиенко А.В., Лукичев Б.Г., Сотников А.В., и др. Факторы риска сердечно-сосудистой патологии у мужчин моложе 60 лет с инфарктом миокарда и нарушением функции почек в разные сезоны года // Нефрология. 2018. T. 22, № 6. С. 64–69. DOI: 10.24884/1561-6274-2018-22-6-64-69

[37] Gordienko AV, Lukichev BG, Sotnikov AV, et al. Glomerular filtration rate seasonal variations in men under 60 years old within acute and subacute period of myocardial infarction. Nephrology (Saint Petersburg). 2021;25(1):70–75. (In Russ.) DOI: 10.36485/1561-6274-2021-25-1-70-75

[38] Гордиенко А.В., Лукичев Б.Г., Сотников А.В., и др. Сезонные изменения клубочковой фильтрации у мужчин моложе 60 лет в остром и подостром периодах инфаркта миокарда // Нефрология. 2021. Т. 25, № 1. С. 70–75.

[39] Gordienko AV, Sotnikov AV, Nosovich DV. Lipid metabolism seasonal variability in men under 60 years old (living in Saint-Petersburg, Russia) within initial period of myocardial infarction. Ateroskleroz i dislipidemii. 2019; (3(36)):12–18. (In Russ.) DOI: 10.34687/2219-8202.JAD.2019.03.0002

[40] Гордиенко А.В., Сотников А.В., Носович Д.В. Сезонная вариабельность состояния липидного обмена у мужчин моложе 60 лет, жителей Санкт-Петербурга, в начальные периоды инфаркта миокарда // Атеросклероз и дислипидемии. 2019. № 3(36). C. 12–18. DOI: 10.34687/2219-8202.JAD.2019.03.0002

[41] Boytsov SA, Pogosova NV, Bubnova MG, et al. Cardiovascular prevention 2017. National guidelines. Russian Journal Cardiology. 2018;23(6):7–122. (In Russ.) DOI: 10.15829/1560-4071-2018-6-7-122

[42] Бойцов С.А., Погосова Н.В., Бубнова М.Г., и др. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации // Российский кардиологический журнал. 2018. Т. 23, № 6. С. 7–122.

[43] Kobalava ZhD, Konradi AO, Nedogoda SV, et al. Russian society of cardiology position paper on 2018 guidelines of the European society of cardiology/European society of arterial hypertension for the management of arterial hypertension. Russian Journal Cardiology. 2018;23(12):131–142. (In Russ.) DOI: 10.15829/1560-4071-2018-12-131-142

[44] Кобалава Ж.Д., Конради А.О., Недогода С.В., и др. Меморандум экспертов российского кардиологического общества по рекомендациям европейского общества кардиологов/европейского общества по артериальной гипертензии по лечению артериальной гипертензии 2018 г. // Российский кардиологический журнал. 2018. Т. 23, № 12. С. 131–142.

[45] Sotnikov AV, Epifanov SYu, Kudinova AN, et al. Clinical features of myocardial infarction with reinfarction and early post-infarction angina among men younger than 60 years. Medical & pharmaceutical journal “Pulse”. 2019;21(9):29–36. (In Russ.) DOI: 10.26787/nydha-2686-6838-2019-21-9-29-36

[46] Сотников А.В., Епифанов С.Ю., Кудинова А.Н., и др. Особенности инфаркта миокарда с рецидивирующим течением и ранней постинфарктной стенокардией у мужчин моложе 60 лет // Медико-фармацевтический журнал Пульс. 2019. Т. 21, № 9. С. 29–36. DOI: 10.26787/nydha-2686-6838-2019-21-9-29-36

[47] Gordienko AV, Sotnikov AV, Nosovich DV. Seasonal features of myocardial infarction in men of young and middle age. The Journal of scientific articles “Health and Education Millenium”. 2017;19(10): 65–70. (In Russ.)

[48] Гордиенко А.В., Сотников А.В., Носович Д.В. Сезонные особенности инфаркта миокарда у мужчин молодого и среднего возраста // Здоровье и образование в XXI веке. 2017. Т. 19, № 10. С. 65–70.

[49] Tereshchenko SN, Galyavich AS, Uskach TM, et al. 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):311–374. (In Russ.) DOI: 10.15829/1560-4071-2020-4083

[50] Терещенко С.Н., Галявич А.С., Ускач Т.М., и др. Хроническая сердечная недостаточность. Клинические рекомендации 2020 // Российский кардиологический журнал. 2020. Т. 25, № 11. С. 311–374. DOI: 10.15829/1560-4071-2020-4083

[51] Carbone A, Al Salhi Y, Tasca A, et al. Obesity and kidney stone disease: a systematic review. Minerva Urol Nefrol. 2018;70(4): 393–400. DOI: 10.23736/S0393-2249.18.03113-2

[52] Carbone A., Al Salhi Y., Tasca A., et al. Obesity and kidney stone disease: a systematic review // Minerva Urol. Nefrol. 2018. Vol. 70, No. 4. P. 393–400. DOI: 10.23736/S0393-2249.18.03113-2

[53] Khalid SH, Liaqat I, Mallhi TH, et al. Impact of diabetes mellitus on clinico-laboratory characteristics and in-hospital clinical outcomes among patients with myocardial infarction. J Pak Med Assoc. 2020;70(12(B)):2376–2382. DOI: 10.47391/JPMA.370

[54] Khalid S.H., Liaqat I., Mallhi T.H., et al. Impact of diabetes mellitus on clinico-laboratory characteristics and in-hospital clinical outcomes among patients with myocardial infarction // J. Pak. Med. Assoc. 2020. Vol. 70, No. 12(B). P. 2376–2382. DOI: 10.47391/JPMA.370

[55] Melhem AJ Jr, Araújo AC, Figueiredo FNS, Figueiredo DLA. Acute Myocardial Infarction in a Young Bodybuilder: A Case Report and Review of the Literature. Am J Case Rep. 2020;21:e924796. DOI: 10.12659/AJCR.924796

[56] Melhem A.J. Jr., Araújo A.C., Figueiredo F.N.S., Figueiredo D.L.A. Acute Myocardial Infarction in a Young Bodybuilder: A Case Report and Review of the Literature // Am. J. Case Rep. 2020. Vol. 21. P. e924796. DOI: 10.12659/AJCR.924796

[57] Margulis AV, Hallas J, Pottegård A, et al. Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study. Eur J Clin Pharmacol. 2018;74(2):193–199. DOI: 10.1007/s00228-017-2359-3

[58] Margulis A.V., Hallas J., Pottegård A., et al. Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study // Eur. J. Clin. Pharmacol. 2018. Vol. 74, No. 2. P. 193–199. DOI: 10.1007/s00228-017-2359-3

[59] Arana A, Margulis AV, McQuay LJ, et al. Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study. Pharmacotherapy. 2018;38(6):628–637. DOI: 10.1002/phar.2121

[60] Arana A., Margulis A.V., McQuay L.J., et al. Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study // Pharmacotherapy. 2018. Vol. 38, No. 6. P. 628–637. DOI: 10.1002/phar.2121

RIGHTS & PERMISSIONS

Izmukhanov A.S., Rejza V.A.